Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Lorraine J. Gudas is active.

Publication


Featured researches published by Lorraine J. Gudas.


Cell | 1978

Deoxyadenosine metabolism and cytotoxicity in cultured mouse T lymphoma cells: a model for immunodeficiency disease

Buddy Ullman; Lorraine J. Gudas; Amos Cohen; David W. Martin

Abstract The inherited absence of either adenosine deaminase (ADA) or purine nucleoside phosphorylase is associated with severe immunological impairment. We have developed a cell culture model using a mouse T cell lymphoma to simulate ADA deficiency and to study the relationship between purine salvage enzymes and immune function. 2′-deoxyadenosine triphosphate (deoxyATP) levels have been shown to be greatly elevated in erythrocytes of immunodeficient, ADA-deficient patients, suggesting that deoxyadenosine is the potentially toxic substrate in ADA deficiency. Using a potent ADA inhibitor, we have demonstrated that deoxyadenosine is growth-inhibitory and cytotoxic to S49 cells, and that deoxyATP accumulates in these cells. Cell variants, unable to transport or phosphorylate deoxyadenosine, are much less sensitive to deoxyadenosine, indicating that intracellular phosphorylation of deoxyadenosine is required for the lethal effects. We have partially reversed the cytotoxic effects of deoxyadenosine with deoxycytidine in wild-type cells, but we cannot show any reversal in cell lines lacking deoxycytidine kinase. Adenosine (ado) kinase-deficient cells are extremely resistant to deoxyadenosine in the presence of deoxycytidine. This deoxycytidine reversal of deoxyadenosine toxicity is consistent with an inhibition of ribonucleotide reductase by deoxyATP, and we have shown that incubation of S49 cells with deoxyadenosine markedly reduces intracellular levels of deoxyCTP, deoxyGTP and TTP. Kinetics data in wild-type cells and in cell variants are consistent with the presence of two deoxyadenosine-phosphorylating activities — one associated with ado kinase and another associated with deoxycytidine kinase. The S49 cells appear to be a valid model for the simulation of ADA deficiency in cell culture, and from our results, we can suggest administration of deoxycytidine as a pharmacological regimen to circumvent the clinicopathologic symptoms in ADA deficiency.


Journal of Clinical Investigation | 1978

Deoxyguanosine Triphosphate as a Possible Toxic Metabolite in the Immunodeficiency Associated with Purine Nucleoside Phosphorylase Deficiency

Amos Cohen; Lorraine J. Gudas; Arthur J. Ammann; Gerard E. J. Staal; David W. Martin

Purine nucleoside phosphorylase (PNP) deficiency is associated with a severe defect in thymus-derived (T)-lymphocyte function combined with normal bone marrow-derived (B)-lymphocyte function. To investigate the role of this enzyme deficiency in the resulting immune dysfunction, we measured the levels of ribonucleoside and deoxyribonucleoside triphosphates in erythrocytes from two unrelated PNP-deficient, T-lymphocyte-deficient patients. Both PNP-deficient patients have abnormally high levels of deoxyguanosine triphosphate (deoxy-GTP) in their erythrocytes (5 and 8 nmol/ml packed erythrocytes). In contrast, normal controls and adenosine deaminase-deficient, immunodeficient patients do not have detectable amounts of deoxyGTP (<0.5 nmol/ml packed erythrocytes). We propose that deoxyguanosine, a substrate of PNP, is the potentially lymphotoxic metabolite in PNP deficiency. The mechanism of toxicity involves phosphorylation of deoxyguanosine to deoxyGTP, which acts as a potent inhibitor of mammalian ribonucleotide reductase.


Cell | 1978

Deoxyguanosine toxicity in a mouse t lymphoma. Relationship to purine nucleoside phosphorylase-associated immune dysfunction.

Lorraine J. Gudas; Buddy Ullman; Amos Cohen; David W. Martin

Abstract The absence of either of the enzymes adenosine deaminase (ADA) or purine nucleoside phosphorylase is associated with an immunodeficiency disease. Because all four nucleoside substrates of the enzyme purine nucleoside phosphorylase accumulate in the urine of patients who lack this enzyme (Cohen et al., 1976), we examined the toxicity of each of the four substrates using a mouse T cell lymphoma (S49) in continuous culture. Of the four substrates (inosine, deoxyinosine, guanosine and deoxyguanosine), only deoxyguanosine is cytotoxic at concentrations lower than 100 μM; furthermore, only deoxyguanosine is directly phosphorylated in S49 cells. Mutant S49 cells lacking deoxycytidine kinase (EC 2.7.1.74) are resistant to the toxic effects of deoxyguanosine, and these same mutants do not phosphorylate deoxyguanosine. Thus the cytotoxicity of exogenous deoxyguanosine correlates with the intracellular concentration of accumulated deoxyGTP. The addition of deoxyguanosine results in the depletion of deoxyCTP in S49 cells, indicating that deoxyGTP is an inhibitor of ribonucleotide reductase. Furthermore, the addition of deoxycytidine prevents the toxic effects of deoxyguanosine. Thus a therapy for purine nucleoside phosphorylase-deficient patients might include deoxycytidine to alleviate the proposed deoxyCTP starvation in those tissues capable of phosphorylating deoxyguanosine.


Somatic Cell and Molecular Genetics | 1978

Analysis of adenosine-mediated pyrimidine starvation using cultured wild-type and mutant mouse T-lymphoma cells.

Lorraine J. Gudas; Amos Cohen; Buddy Ullman; David W. Martin

Using the S49 T-cell lymphoma system for the study of immunodeficiency diseases, we characterized several variants in purine salvage and transport pathways and studied their responses to the cytotoxic action of adenosine (5–20 μM) in the presence of adenosine deaminase (ADA) inhibitors. Both an adenosine transport deficient mutant and a mutant lacking adenosine (ado) kinase activity are resistant to the cytotoxic effects of adenosine up to 15 μM. Variants lacking hypoxanthine-guanine phosphoribosyl transferase or adenine phosphoribosyltransferase are sensitive to the killing action of adenosine. We monitored the intracellular concentrations of purine and pyrimidine nucleotides, orotate, and PPribose P in mutant and wild-type cells following the addition of adenosine and an ADA inhibitor. We conclude that at low concentrations, adenosine must be phosphorylated to deplete the cell of pyrimidine nucleotides and PPribose P and to promote the accumulation of orotate. These alterations account for one mechanism of adenosine toxicity.


Biochemical Genetics | 1980

Characterization of the subunit composition of HGPRTase from human erythrocytes and cultured fibroblasts

Vassilis I. Zannis; Lorraine J. Gudas; David W. Martin

Hypoxanthine-guanine phosphoribosyltransferase is a ubiquitous human enzyme, the inherited deficiency of which leads to a specific metabolic-neurological syndrome. Native acrylamide isoelectric focusing revealed that the human enzyme consists of different numbers of isoenzymes depending on the tissue of origin. The erythrocytic enzyme has the most isoenzymes while the enzyme from cultured fibroblasts has only a single isoenzyme. The isoenzyme pattern of the erythrocytic enzyme changes on storage of the crude hemolysate at 4 C. Treatment of the stored crude hemolysate with 4.5 m urea and 0.35mm β-mercaptoethanol results in an isoenzyme pattern similar to that of the fresh crude extract. Thus the additional isoenzymes are generated on storage not by covalent modification of the enzyme but probably by binding of small molecules to the enzyme or to association of the enzyme molecules. Hypoxanthine-guanine phosphoribosyltransferase has been purified to 80% homogeneity in three steps, DEAE Sephadex chromatography, heat treatment at 85 C for 5 min, and hydroxylapatite chromatography. Denaturing two-dimensional gel electrophoresis of the erythrocytic enzyme revealed that the erythrocytic enzyme is composed of three major types of subunits (1–3) with the same molecular weight but different isoelectric points. In contrast, the fibroblast enzyme is composed of only a single type of subunit, which comigrates with subunit 1 of the erythrocytic enzyme. Since there is a single genetic locus in humans for HGPRTase (the enzyme is X linked) (Nyhan et al., 1967), the observed subunit modification of the erythrocyte enzyme appears to be the result of posttranslational modification. These findings provide a simple explanation for the observed electrophoretic properties of human HGPRTase. A patient with 0.5% of HGPRTase activity in his erythrocytes was found to have small amounts (> 0.5% but < 5% of normal) of the erythrocytic HGPRTase subunits.


Advances in Enzyme Regulation | 1981

Purification of a mutant ribonucleotide reductase from cultured mouse T-lymphoma cells

Lorraine J. Gudas; Staffan Eriksson; Buddy Ullman; David T. Martin

Abstract Ribonucleotide reductase has been partially purified from a mutant line of S49 mouse T-lymphoma cells which is less sensitive to normal feedback control by deoxyATP. The mutation for deoxyATP feedback resistance resides in the M1 subunit in this mutant. The mutant appears to contain two alleles for ribonucleotide reductase, a mutant allele and a wild type allele, which can be separated by affinity chromatography on deoxyATP-Sepharose.


Biochemical Genetics | 1979

Characterization of the subunits of purine nucleoside phosphorylase from cultured normal human fibroblasts

Vassilis I. Zannis; Lorraine J. Gudas; David W. Martin

In previous communications we have demonstrated that the subunits of normal human erythrocyte purine nucleoside phosphorylase can be resolved into four major (1–4) and two minor (1p and 2p) components with the same molecular weight but different apparent isoelectric points (and net ionic charge). The existence of subunits with different charge results in a complex isoelectric focusing pattern of the native erythrocytic enzyme. In contrast, the isoelectric focusing pattern of the native enzyme obtained from cultured human fibroblasts is simpler. The multiple native isoenzymes obtained from human erythrocytes and human brain have isoelectric points ranging from 5.0 to 6.4 and from 5.2 to 5.8, respectively, whereas cultured human fibroblasts have two major native isoenzymes with apparent isoelectric points of 5.1 and 5.6.Purine nucleoside phosphorylase has been purified at least a hundredfold from 35S-labeled cultured human fibroblasts. A two-dimensional electrophoretic analysis of the denatured purified normal fibroblast enzyme revealed that it consists mainly of subunit 1 (90%) with small amounts of subunits 2 (10%) and 3 (1%). This accounts for the observed differences between the native isoelectric focusing and the electrophoretic patterns of the erythrocyte and fibroblast enzymes. The purine nucleoside phosphorylase subunit 1 is detectable in the autoradiogram from a two-dimensional electrophoretic analysis of a crude, unpurified extract of 35S-labeled cultured normal human fibroblasts. The fibroblast phosphorylase coincides with the erythrocytic subunit 1 of the same enzyme, and the cultured fibroblasts of a purine nucleoside phosphorylase deficient patient (patient I) lack this protein component, genetically confirming the identity of the purine nucleoside phosphorylase subunit in cultured fibroblasts.


DNA Repair Mechanisms | 1978

AN ESCHERICHIA COLI MUTANT WITH AN ALTERED INDUCIBLE rec + /lex + DEPENDENT DNA REPAIR PATHWAY

Lorraine J. Gudas; David W. Mount

ABSTRACT The mutant DM1285, a spontaneous derivative of DM1187 ( lex A spr tif sfi ) (PNAS 74 :300–304), makes turbid plagues with +phage, and clear plaques with inds phage. DM1285 maps at the lex A locus at 90 min. on the E. coli K-12 genetic map. After addition of nalidixic acid or mitomycin C, the mutant DM1285 exhibits unusual kinetics of induction of protein X, the rec A gene product (PNAS 74 :5280–5284). At concentrations of mitomycin C (20μg/ml) which induce the rec A protein in the wild type strain, JM1( lex A+ spr + sfi +), only a small amount of rec A protein is induced in strain DM1285. After nalidixic acid addition (25μg/ml), the rec A protein is synthesized at an increasing rate with time in JM1 and DM1187; in DM1285, only a burst of rec A protein synthesis occurs. Two dimensional gel anlysis demonstrated that the pI of the rec A protein in strain DM1285 was not altered, as compared to its parent, DM1187. Survival of UV-irradiated phage was two - four times higher on unirradiated DM1285 as compared to unirradiated JM1. However, UV-irradiation of DM1285 resulted in no greater than a five-fold increase in survival of the irradiated phage, whereas UV-irradiation of JM1 resulted in a 20–50 fold increase in phage survival.


Advances in Experimental Medicine and Biology | 1980

Abnormal regulation of purine metabolism in a cultured mouse T-cell lymphoma mutant partially deficient in adenylosuccinate synthetase.

Buddy Ullman; M. A. Wormsted; B. B. Levinson; Lorraine J. Gudas; Amos Cohen; Shirley M. Clift; David W. Martin

The isolation and characterization of a mutant mouse T-cell lymphoma (S49) with altered purine metabolism is described. This mutant, AU-100, was isolated from a mutagenized population of S49 cells by virtue of its resistance to 0.1 mM 6-azauridine in semisolid agarose. The AU-100 cells are resistant to adenosine mediated cytotoxicity but are extraordinarily sensitive to killing by guanosine. High performance liquid chromatography of AU-100 cell extracts has demonstrated that intracellular levels of GTP, IMP, and GMP are all elevated about 3-fold over those levels found in wild type cells. The AU-100 cells also contain an elevated intracellular level of pyrophosphoribosylphosphate (PPriboseP), which accounts for its resistance to adenosine. However AU-100 cells synthesize purines de novo at a rate less than 35% of that found in wild type cells. Furthermore, the intact cells of this mutant S49 cell line cannot efficiently incorporate labeled hypoxanthine into nucleotides since the salvage enzyme HGPRTase is inhibited in situ. The AU-100 cell line was found to be 80% deficient in adenylosuccinate synthetase, but these cells are not auxotrophic for adenosine or other purines. The significant alterations in the control of purine de novo and salvage metabolism caused by the defect in adenylosuccinate synthetase are mediated by the resulting increased levels of guanosine nucleotides.


Advances in Experimental Medicine and Biology | 1977

Purification and characterization of hypoxanthine-guanine phosphoribosyl transferase from cultured HTC cells.

Vassilis I. Zannis; Lorraine J. Gudas; Deborah Doyle; David W. Martin

Hypoxanthine-guanine phosphoribosyl transferase (HGPRTase.) from |35S|-methionyl-labelled rat hepatoma (HTC) cells has been purified more than 600-fold to near homogeneity by making use of conventional and affinity chromatographic techniques (Table 1). The conventional purification procedure utilizes a pH 5.0 precipitation, an ammonium sulfate precipitation, DEAE-cellulose chromatography, and heating at 80–85°according to the method of Olsen and Milman, 1974. Using this procedure, a partially pure enzyme preparation is obtained. Affinity chromatography according to Hughes et al., 1975, can be used either before or after the DEAE step to yield pure enzyme.

Collaboration


Dive into the Lorraine J. Gudas's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Buddy Ullman

University of California

View shared research outputs
Top Co-Authors

Avatar

Amos Cohen

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

S Eriksson

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

B. B. Levinson

University of California

View shared research outputs
Top Co-Authors

Avatar

I W Caras

University of California

View shared research outputs
Top Co-Authors

Avatar

M. A. Wormsted

University of California

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge